RecruitingNot ApplicableNCT06768827

New Mechanisms of Obesity

Pathogenic Mechanisms of Obesity and Its Cardiometabolic Complications


Sponsor

Yale University

Enrollment

55 participants

Start Date

Nov 13, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Given the pervasiveness of Pediatric Obesity, it is imperative to understand its pathophysiology and develop alternative strategies to reverse this condition. Herein, investigators propose to elucidate the interaction between colonic fermentation and insulin resistance in modulating metabolism in youth with obesity.


Eligibility

Min Age: 15 YearsMax Age: 22 Years

Inclusion Criteria3

  • Age 15 to 22 years
  • In puberty (girls and boys: Tanner stage III-V);
  • BMI \>85th

Exclusion Criteria5

  • Pregnancy;
  • endocrinopathies (e.g., Cushing syndrome);
  • substance abuse;
  • medications affecting insulin resistance such as metformin, GLP-1 analogues; -
  • high fibers intake (\> 30g/day) as assessed by a 3-day food record.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERLactulose Oral Product

Each arm will undergo a study to induce colonic fermentation through lactulose at the beginning and at the end of the 12 weeks.


Locations(1)

Yale University

New Haven, Connecticut, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06768827


Related Trials